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Abstract
Background: Postpartum depression is associated with reduced breastfeeding duration. We previously hy-
pothesized that shared neuroendocrine mechanisms underlie this association. We sought to measure the asso-
ciation between maternal mood and neuroendocrine response to breastfeeding.
Methods: We conducted a longitudinal cohort study of women recruited during pregnancy who intended to
breastfeed. Baseline depression and anxiety history were assessed with a structured clinical interview. We
measured mood symptoms using validated psychometric instruments, and we quantified affect and neuroen-
docrine responses to breastfeeding during laboratory visits at 2 and 8 weeks postpartum.
Results: We recruited 52 women who intended to breastfeed, among whom 47 completed 8-week follow-up.
Duration and intensity of breastfeeding through 8 weeks were similar among mothers with lower versus higher
anxiety and depression scores. In the third trimester, oxytocin was inversely correlated with Edinburgh Postnatal
Depression Scale (EPDS) score ( p = 0.03). We did not find differences in neuroendocrine profile during breast-
feeding at 2 weeks postpartum. Among the 39 women who breastfed at 8 weeks postpartum, oxytocin area
under the curve during breastfeeding was inversely correlated with maternal EPDS and STAI-State and STAI-
Trait anxiety scores (all p £ 0.01). Higher anxiety and depression scores was further associated with lower
oxytocin (group p < 0.05) during feeding. During feeding at both visits, higher anxiety and depression scores
were also associated with more negative affect: mothers reported feeling less happy and more depressed,
overwhelmed, and stressed during feeding than women with lower scores.
Conclusion: Symptoms of depression and anxiety were associated with differences in oxytocin response and
affect during breastfeeding.
Introduction
In the first weeks after childbirth, mother and infantnavigate a complex transition from the physiology of
pregnancy to the early postpartum period. Key challenges
for the mother include adjusting to loss of placental hor-
mones, establishing lactation, and coping with the stressor of
caring for a new infant. Difficulties with this transition may
present clinically as postpartum depression (PPD) and failed
lactation.1
Both depression and curtailed breastfeeding confer sub-
stantial morbidity for mother and child. Postpartum de-
pression is associated with impaired parenting behavior,
diminished maternal-infant attachment, and, in extreme
cases, maternal suicide and infanticide.2–4 Prominent anxiety
symptoms are a distinguishing feature of postpartum de-
pression, and many women seeking treatment have primary
complaints of ruminating and obsessive thoughts.5,6 Never
breastfeeding or early weaning is associated with increased
infant risk of infectious morbidity and chronic disease, as
well as increased maternal risk of breast and ovarian cancer,
type 2 diabetes, hypertension, and myocardial infarction.7–10
Observational studies have reported associations be-
tween postpartum depression and both early weaning and
negative breastfeeding experiences.11–15 However, the
mechanisms underlying these associations remain to be
determined. Several neuroendocrine mechanisms, including
gonadal steroids, oxytocin, prolactin, the hypothalamic
Preliminary results were presented at the 58th Annual Meeting of the Society for Gynecologic Investigation, Miami, Florida, March 2011,
and at the 66th Meeting of the Society Biological Psychiatry, San Francisco, California, May 2011.
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology and 3Department of Psychiatry, University of North
Carolina School of Medicine, Chapel Hill, North Carolina.
2Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North
Carolina.
JOURNAL OF WOMEN’S HEALTH
Volume 22, Number 4, 2013
ª Mary Ann Liebert, Inc.
DOI: 10.1089/jwh.2012.3768
352
pituitary adrenal axis, and the thyroid, are implicated in
both maternal mood and breastfeeding physiology, as we
have previously reviewed.1 We hypothesized that mater-
nal postpartum mood symptoms and unplanned early
weaning share a common pathogenesis that involves alter-
ations in neuroendocrine function. Identifying such shared
mechanisms may lead to new therapeutic options for re-
ducing the morbidity of both postpartum depression and
early weaning.
No studies to our knowledge have measured maternal
neuroendocrine response to breastfeeding among mothers
with and without mood symptoms. Defining such differences
may both elucidate physiologic changes underlying perinatal
mood disorders and identify novel targets for prevention and
treatment. We hypothesized that maternal depression and
anxiety symptoms would be associated with shorter breast-
feeding duration and with differences in affect and neuroen-
docrine response to infant feeding. To test this hypothesis, we
recruited a prospective cohort of women in the third trimester
of pregnancy who intended to breastfeed, and we measured
neuroendocrine response and affect during feeding sessions
at 2 and 8 weeks postpartum.
Materials and Methods
Study participants were recruited from prenatal obstetric
and perinatal psychiatry clinics at University of North
Carolina (UNC) Hospitals from February 2010 to February
2011. Women in the third trimester of a singleton pregnancy
who intended to breastfeed for at least 3 months were in-
vited to participate. We limited our enrollment to women
intending to breastfeed at least 3 months so that any
weaning during the study period would be unplanned. We
planned to recruit 25 women with current or past depression
or anxiety and 25 women with no such history, anticipating
that 10% of the women without a history of mood disorders
would develop postpartum depression based on a conser-
vative estimate of prevalence of PPD.16 Assuming 28 women
with postnatal symptoms and 22 without symptoms, this
sample size provided 80% power to detect a 0.82 standard
deviation (SD) difference in continuous measures between
symptomatic and asymptomatic women. We excluded wo-
men with (1) diagnosis of Axis I disorders other than uni-
polar depression or anxiety disorders, (2) use of tobacco or
illicit substances, (3) prenatal diagnosis of congenital
anomaly likely to interfere with breastfeeding, (4) maternal
endocrine disorder associated with low milk supply, in-
cluding thyroid disorder and pregestational diabetes, or (5)
chronic medication that is contraindicated during lactation.
The UNC Institutional Review Board approved the study,
and all participants provided written informed consent.
Women were enrolled in the third trimester of pregnancy
and were assessed by a board-certified psychiatrist with
extensive training in administration of structured research
interviews (SMB) using the depression and anxiety disorder
modules of the Structured Clinical Interview Non-Patient
version (SCID-NP).17 In addition, participants provided a
morning non-fasting blood sample. At enrollment in the
third trimester and at 2- and 8-weeks postpartum, mothers
completed the Edinburgh Postnatal Depression Scale
(EPDS)18 and the Spielberger State and Trait Anxiety In-
ventories (STAI).19
Edinburgh postnatal depression scale
The EPDS was developed specifically for assessing post-
partum depression and relies much less than standard de-
pression screens on somatic, or physical, questions.20 It also
has multiple questions that specifically assess for anxiety
symptoms.21 The EPDS is a widely validated instrument
commonly used internationally to assess postpartum de-
pression. The 10-item EPDS is a self-report screening scale and
the response format is frequency-based. A cutoff of score of
‡ 12 on the EPDS has been consistently shown to be correlated
with a clinical diagnosis of major depressive disorder, when
compared with a structured clinical interview.20 EPDS scores
of 10–12 have been associated with an accurate diagnosis of
minor depressive disorder. Multiple reports in the literature
have documented that the EPDS demonstrates good sensi-
tivity and specificity in identifying women suffering from
perinatal depression.16 In our analysis, we used a cutoff score
of ‡ 10 as a positive screen.
Spielberger State and Trait Anxiety Inventory
We quantified anxiety symptoms using the Spielberger
STAI.19 For the trait inventory, participants rate how they
generally feel, using a four-level Likert scale ranging from
‘‘almost never’’ to ‘‘almost always’’ to rate statements such as
‘‘I feel satisfied with myself,’’ ‘‘I have disturbing thoughts,’’
and ‘‘I make decisions easily.’’ For the state inventory, par-
ticipants rate their feelings at this moment, using a four-level
Likert scale ranging from ‘‘not at all’’ to ‘‘very much so’’ to
rate 20 statements such as ‘‘I feel calm,’’ ‘‘I feel nervous,’’ or ‘‘I
feed content.’’ The trait inventory provides a stable measure
of anxiety, whereas the state inventory captures perceived
stress ‘‘right now’’ (Alpha = 0.90 to 0.94 and 0.89 to 0.92, re-
spectively). Because we sought to measure current maternal
anxiety, we used the state inventory to quantify anxiety
symptoms in our study population. The Spielberger STAI
has been validated in for use in perinatal populations.22
Population normative data shows that the median score for
both state and trait anxiety among women ages 19–39 is 34.19
Breastfeeding intensity
Breastfeeding intensity was assessed at 2 and 8 weeks post-
partum with a 1-week infant feeding recall and was defined as
the percentage of all milk feedings that were breast milk.23
Mothers were asked to report how many times in the last day
they had fed their infant breast milk, formula, or other foods. If
they had not fed the food in the past day, they were asked how
many times they had fed the food in the past week. Breast-
feeding intensity was calculated as [number of breast milk
feedings per week / (number of breast milk feedings + formula
feedings per week)]. For example, if a mother breastfed 8 times
a day and fed her infant formula twice in the past week, her
breastfeeding intensity was calculated as (breastfed 8 times a
day · 7 days) / [(breastfed 8 times a day · 7 days) + (formula fed
2 times)] = 56 / (56 + 2) = breastfeeding intensity of 96.5%. All
participants had access to lactation support through the North
Carolina Women’s Hospital Breastfeeding WarmLine.
Observed feeding session
At 2 and 8 weeks postpartum, mothers brought their in-
fants to the Mother-Infant Biobehavioral Laboratory for an
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afternoon observed feeding session beginning at 1:00 p.m. An
antecubital i.v. was placed in the mother’s arm to enable
multiple blood draws at predetermined intervals. After a 10-
minute habituation period and 10 minutes of baseline rest, a
venous blood sample was obtained. Mothers chose to
breastfeed, express milk using an electronic pump, or both
breast- and bottle-feed at each study visit, as best reflected
their usual feeding routine. We used this approach so that we
could quantify the neuroendocrine profile of a typical feeding
session for each mother-infant dyad. During the 2-week visit,
46 mothers expressed milk or breastfed, and during the 8-
week visit, 39 mothers expressed milk or breastfed. One mo-
ther used an electronic pump to express milk during both the
2-week and 8-week visit. A second mother breastfed and then
supplemented with a bottle at the 2-week visit. Two mothers
were taking fenugreek, an herbal galactogogue used to in-
crease milk supply, at both the 2- and 8-week visits. One
mother was using hormonal contraception at the 8-week visit.
Samples were obtained at the onset of minutes 1, 4, 7, and
10 of the feeding session. Ten minutes after the feeding ended,
a resting blood sample was obtained. At the end of baseline
rest, at minute 10 of feeding, and after 10 minutes of post-
feeding rest, mothers rated their affect on visual analog scales
in 5 areas: stressed, worried, nervous, or tense; happy, re-
laxed, comfortable, or satisfied; irritated, annoyed, ‘pissed
off,’ or furious; depressed, sad, down or unhappy; and over-
whelmed, unable to control things, or discouraged (0 = not at
all; 9 = extremely).
Neuroendocrine marker assessment
Because oxytocin release is pulsatile, we measured levels at
baseline, at 1, 3, 7, and 10 minutes of feeding, and after a post-
feeding rest. Other markers were measured at baseline only
(estradiol, progesterone), at baseline, minute 10, and after
feeding (prolactin) or at baseline and after feeding (cortisol,
corticotropin releasing factor [CRF], free T4, and total T4).
Each venous blood sample was collected into pre-chilled va-
cutainer tubes, immediately cold-centrifuged, aliquoted into
pre-chilled cryotubes, and stored at –80C for later endocrine
assays. The level of oxytocin in EDTA-treated plasma, with
aprotinin added to prevent peptide degradation, was deter-
mined by enzyme immunoassay (EIA) with extraction (Enzo
Life Sciences) as per previously described methods.24 The level
of detection was 1.1 pg/mL, with intra- and inter-assay CV of
4.6 and 8.7 respectively. We used commercial EIA to measure
T4, free T4, estradiol, progesterone, and cortisol, commercial
radioimmunoassay (RIA) to measure prolactin (MP Biome-
dicals), and high sensitivity EIA to measure CRF (Bachem).
Statistical analysis
Characteristics of the study population were measured us-
ing chi-square tests or Fisher’s exact tests for categorical vari-
ables and analysis of variance for continuous variables. To
determine whether maternal depression or anxiety history was
associated with subsequent breastfeeding, we used Cox pro-
portional hazards regression to model the association between
prenatal depression or anxiety, assessed by diagnostic inter-
view at enrollment, mood symptoms at each study time point,
and timing of introduction of formula and of weaning alto-
gether. We reported median values and interquartile ranges for
breastfeeding intensity because this measure was not normally
distributed, and we used the Kruskal-Wallis test to determine
whether prenatal history of depression or anxiety or higher
versus lower depression or anxiety symptoms were associated
with breastfeeding intensity at the 2- and 8-week visits.
To quantify associations between maternal mood and
neuroendocrine profile, we measured Spearman correlations
between EPDS, STAI State and Trait anxiety scales, and
neuroendocrine markers. We included all participants for
correlations between mood measures and baseline neuroen-
docrine markers, and we included those mothers who
breastfed or pumped during each study visit for correlations
between mood measures and post-feeding measures. Because
oxytocin levels vary due to pulsatile release, a composite
variable was created for oxytocin, using area under the curve
(AUC)25 to reflect overall oxytocin across the feeding session.
We used repeated measures analysis to quantify the associa-
tion between subclinical anxiety and/or depression and
profiles of oxytocin, prolactin, cortisol, CRF, T4, and free T4
among mothers who breastfed or pumped at the postpartum
study visits, adjusting for days postpartum and parity (0 or
1 + ). Residuals were tested for normality, and, if non-normal,
neuroendocrine markers were log transformed.
To measure associations between higher versus lower
maternal symptoms and affect during feeding, we initially
used repeated measures analysis. However, residuals were
not normally distributed, and due to the large number of
scores of 0, results were not amenable to transformation. We
therefore compared median affect scores and interquartile
ranges, using Wilcoxon rank sum tests to compare affect at
baseline, minute 10 of feeding, and post-feeding rest.
Our study population included women with and without
mood symptoms who were taking antidepressants. To test
whether current antidepressant use modified associations be-
tween mood symptoms and neuroendocrine profile, we tested
for interactions between current medication use and subclinical
depression and/or anxiety using a cross-product term. For all
models, p values < 0.05 were considered statistically significant.
Results
We recruited 52 women during the third trimester. Of
these, 4 participants dropped out of the study before the 2-
week postpartum visit. An additional participant dropped
out before the 8-week visit, leaving 47 women for analysis
who completed all three visits (Fig. 1). Among those who did
not complete the 2-week visit, 1 had no prior history of de-
pression or anxiety, 1 had a past history, and 2 were currently
depressed or anxious at enrollment. One additional partici-
pant who was currently depressed or anxious at enrollment
did not attend the 8-week visit.
Among those who completed the study, 23 had no history
of depression or anxiety, 16 had a lifetime history, and 8 were
currently depressed or anxious based on diagnostic interview
at enrollment. The three groups were similar in age, race/
ethnicity, income, and education (Table 1). Women with no
depression or anxiety history were more likely to be primip-
arous (58.3% vs. 41.7%; chi square p = 0.07). At baseline and
during follow-up, women with past or current depression or
anxiety were more likely to meet criteria for mild depression,
defined as EPDS ‡ 10; and higher anxiety, defined as STAI
‡ 34; and for Fisher’s exact p < 0.05 for mild depression pre-
natally and at 8 weeks; and for higher anxiety symptoms at all
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three time points. At the final study visit, 54% (13/24) women
with a history of depression or anxiety reported higher de-
pression and/or anxiety symptoms, compared with 4% (1/
23) of women without a prenatal history of depression or
anxiety ( p < 0.01).
At the 2-week visit, all mothers were still breastfeeding, but
2 mothers chose to feed their infants from a bottle during the
study visit, leaving 46 women who breastfed or pumped
during the study visit. At the 8-week visit, 42 mothers were
still breastfeeding, but 2 mothers chose to formula-feed dur-
ing the study visit and one mother chose to hold her baby
without feeding, leaving 39 women who breastfed or pumped
during the study visit. Among the 39 women who breastfed
during the 8-week visit, 15 had subclinical anxiety or de-
pression at 2 weeks, and 11 had subclinical symptoms at 8
weeks. Six had subclinical symptoms at 2 weeks that resolved
by 8 weeks, and 2 developed subclinical symptoms between
the 2- and 8-week visits.
Breastfeeding intensity was high in our study population.
Similar proportions of subclinically symptomatic (71%) and
asymptomatic (73%) women received assistance from a lac-
tation consultant in the first two weeks postpartum (Fisher’s
exact p = 1.0). At 2 weeks, 33 of 48 (68.8%) of mothers were
exclusively breastfeeding, 15 of 48 (31.2%) were supple-
menting with formula, and no mothers had stopped breast-
feeding altogether. At 8 weeks, 33 of 47 (70.2%) of mothers
Table 1. Characteristics of Study Population by Depression/Anxiety History Assessed at Enrollment







n 23 16 8 47
Age, mean (SD) 31.3 (5.2) 32.0 (5.2) 31.8 (2.3) 31.6 (4.8)
Race
White 19 (82.6) 13 (81.3) 7 (87.5) 39 (83.0)
Black or African American 3 (13.0) 3 (18.8) 1 (12.5) 7 (14.9)
Asian 1 (4.3) 0 (0.0) 0 (0.0) 1 (2.1)
Education
< 4-yr college graduate 4 (17.4) 3 (18.8) 1 (12.5) 8 (17.0)
Graduated 4-yr college 4 (17.4) 6 (37.5) 4 (50.0) 14 (29.8)
Post graduate 15 (65.2) 7 (43.8) 3 (37.5) 25 (53.2)
Body mass index
< 25 7 (30.4) 5 (31.3) 3 (37.5) 15 (31.9)
25 to < 30 11 (47.8) 6 (37.5) 4 (50.0) 21 (44.7)
30 + 5 (21.7) 5 (31.3) 1 (12.5) 11 (23.4)
Income
Less than $40,000 6 (27.3) 2 (12.5) 2 (25.0) 10 (21.7)
$40000–59999 4 (18.2) 2 (12.5) 1 (12.5) 7 (15.2)
$60,000–99,999 6 (27.3) 6 (37.5) 3 (37.5) 15 (32.6)
$100,000 or above 6 (27.3) 6 (37.5) 2 (25.0) 14 (30.4)
Primiparous 16 (69.6) 7 (43.8) 3 (37.5) 26 (55.3)
Mode of delivery
Spontaneous vaginal birth 17 (85.0) 9 (69.2) 7 (87.5) 33 (80.5)
Vacuum 0 (0.0) 2 (15.4) 1 (12.5) 3 (7.3)
C-section 3 (15.0) 2 (15.4) 0 (0.0) 5 (12.2)
Depression symptoms (EPDS ‡ 10)
Prenatal 0 (0.0) 1 (6.3) 2 (25.0) 3 (6.4)
2 weeks postpartum 2 (8.7) 5 (31.3) 1 (12.5) 8 (17.0)
8 weeks postpartum 0 (0.0) 2 (12.5) 2 (25.0) 4 (8.5)
Higher anxiety symptoms (STAI-State ‡ 34)
Prenatal 3 (13.0) 4 (25.0) 7 (87.5) 14 (29.8)
2 weeks postpartum 2 (8.7) 7 (43.8) 6 (75.0) 15 (31.9)
8 weeks postpartum 1 (4.3) 8 (50.0) 4 (50.0) 13 (27.7)
*n (%) unless otherwise specified.
SD, standard deviation; EPDS, Edinburgh Postnatal Depression Scale; STAI, State and Trait Anxiety Inventories.







Left study prior to 2-week visit (n=4)
   1 with no history of depression/anxiety
   1 with prior history
   2 with current depression or anxiety
Left study prior to 8-week visit (n=1)
   1 with current depression or anxiety
FIG. 1. Study participant flow chart.
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were exclusively breastfeeding, 9 of 47 (19.2%) were supple-
menting, and 5 of 47 (10.6%) had stopped breastfeeding. The
median breastfeeding intensity was 100% (IQR 94.8%–100%)
at 2 weeks and 100% (IQR 93.3%–100%) at 8 weeks. We found
no association between maternal prenatal depression/anxiety
history or symptoms and concurrent breastfeeding intensity
or exclusivity at 2 or 8 weeks postpartum. Women who were
exclusively breastfeeding at 2 weeks were more likely to re-
port subclinically symptomatic anxiety at 8 weeks (12/32,
37.5%, vs. 1/15, 6.7%; Fisher’s exact p = 0.04). In Cox propor-
tional hazards models, we found no association between
psychiatric history and timing of introduction of formula or of
weaning altogether.
Patterns of association between neuroendocrine markers
and mood differed by study visit. At the prenatal visit
(N = 52), oxytocin was inversely correlated with EPDS score
(Spearman R = –0.30, p = 0.03). We found no association be-
tween prenatal depression, indexed by EPDS, or anxiety, in-
dexed by STAI, and cortisol, CRF, estradiol, progesterone,
prolactin, FT4, or total T4.
At the 2-week visit, we found associations between maternal
mood, baseline oxytocin, and maternal affect during feeding.
Among the 48 women who presented for the 2-week visit,
baseline oxytocin was inversely correlated with EPDS score
(Spearman R = –0.33, p = 0.03). We found no correlations be-
tween maternal EPDS or STAI score and baseline cortisol, CRF,
estradiol, progesterone, prolactin, FT4, or total T4. In repeated
measures analysis among mothers who expressed milk or
breastfed at the 2-week visit (Fig. 3A, N = 46), we found no
differences in oxytocin profile during feeding among mothers
with higher depression/anxiety symptoms (EPDS ‡ 10 and/or
STAI ‡ 34) versus the profile among mothers with lower
symptoms. Mothers with higher symptoms reported feeling
more depressed, overwhelmed, and stressed during feeding
than mothers with lower symptoms ( p < 0.05 for all compari-
son, Fig. 4A). In addition, we observed several non-statistically
significant patterns that may merit exploration in future stud-
ies. Among mothers with higher symptoms, we found lower
prolactin and higher cortisol levels than among mothers with
lower symptoms. When we compared CRF trajectories during
feeding, we found a decrease in CRF among lower-symptom
mothers and an increase among higher-symptom mothers
(group · time, p = 0.09).
At the 8-week visit, we found statistically significant asso-
ciations between maternal mood and oxytocin, total T4, and
affect during feeding. Among the 47 women who attended the
8-week visit, total T4 was inversely correlated with EPDS
(Spearman R = - 0.34; p = 0.03). Among the 39 women who
breastfed or expressed milk during the visit, EPDS and STAI
anxiety scores were inversely correlated with oxytocin mea-
sures during and after feeding (Table 2) and with oxytocin
area under the curve (Fig. 2; Spearman R for EPDS, STAI of
- 0.48, - 0.53, and - 0.44, respectively, all p < 0.01). The cor-
relation between EPDS and oxytocin area under the curve
remained with exclusion of an outlier with an EPDS of 17
(Spearman R = –0.35, p = 0.02). We further found that total T4
before and after feeding was inversely correlated with EPDS
score at 8 weeks (Spearman R = –0.41, p = 0.01 before and R =
- 0.36, p = 0.03 after). We found no significant correlations
between maternal mood measures and baseline cortisol, CRF,
estradiol, progesterone, prolactin, or free T4 (Spearman
p > 0.05 for all correlations).
In repeated measures analyses among women who were
breastfeeding or pumping during the study visit (Fig. 3B,
N = 39), we found lower oxytocin levels during and after
feeding among higher-symptom mothers compared with
lower-symptom mothers (group p < 0.05). Consistent with the
2-week visit, we further found that mothers with higher mood
symptoms reported feeling less happy and more depressed,
overwhelmed, and stressed than mothers with lower mood
symptoms (Fig. 4B, group p < 0.05 for all comparisons).
In addition, we found potentially interesting, but statisti-
cally non-significant, differences in prolactin, cortisol, and
CRF trajectory in repeated measures analysis. As at the 2-
week visit, higher-symptom mothers had lower prolactin and
higher cortisol levels. We again found differences in CRF
trajectory, although at 8 weeks, CRF increased during feeding
among lower-symptom mothers and decreased among
higher-symptom mothers.
When we tested for interactions between maternal antide-
pressant use, higher versus lower symptoms and neuroen-
docrine markers, we found interactions at 2 weeks for both
CRF and Total T4 and at 8 weeks for oxytocin (Fig. 5). At 2
weeks, CRF levels decreased during breastfeeding for women
with lower symptoms, regardless of medication use (n = 26, no
medications; n = 3, with medications), and for women with
higher symptoms who were not taking medication (n = 10).
CRF levels increased during feeding for women who were
taking medication but had higher symptoms (n = 7). Total T4
levels decreased during feeding for lower-symptom women
who were not taking medication and for higher-symptom
women who were taking medication but increased for lower-
symptom women who were taking medication and for
higher-symptom women who were not taking medication. At
the 8-week visit, we found the lowest oxytocin levels among





















Edinburgh Postnatal Depression Scale 
15 25 35 45 55 65 
Spielberger State 
15 25 35 45 55 65 
Spielberger Trait 
FIG. 2. Correlation between
maternal mood at 8 weeks
postpartum and oxytocin
area under the curve during
breastfeeding (n = 39). Spear-
man R: EPDS, R = –0.48,
p < 0.01; STAI-State, R = –0.53,
p < 0.01; STAI-Trait, R = –0.44,
p < 0.01.
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medications (n = 6), followed by lower-symptom women
taking medication (n = 4), higher-symptom women not on
medication (n = 5), and finally, lower-symptom women not
taking medication (n = 24). Higher symptoms of depression/
anxiety and antidepressant medications were similarly asso-
ciated with oxytocin area under the curve at 8 weeks (mean
oxytocin pg/mL-minutes [SD] for each: lower symptoms/no
antidepressants: 139.9 [34.7]; higher symptoms/no antide-
pressants: 111.7 [23.1]; lower symptoms/antidepressants:
108.5 [11.1]; higher symptoms/antidepressants: 100.6 [30.0],
ANOVA p = 0.02).
Discussion
In a longitudinal study of women intending to breastfeed,
we found differences in oxytocin profile and affect during
feeding among women with lower vs. higher mood symp-
toms. Consistent with our hypothesis, higher depression and
anxiety symptoms were correlated with lower levels of oxy-
tocin. We further found that depression scores at 8 weeks
were correlated with lower total T4. Contrary to our hy-
pothesis, we did not find differences in duration or exclusive
or any breastfeeding by maternal depression/anxiety history,
nor did we find statistically significant associations between
mood history or symptoms and gonadal steroids, cortisol,
CRF, prolactin, or free T4.
FIG. 3. Maternal neuroen-
docrine profile during
breastfeeding sessions at 2
weeks postpartum (A) and 8
weeks postpartum (B),
among mothers with higher
(dashed line) versus lower
(solid line) mood symptoms,
defined as EPDS ‡ 10 and/or
Spielberger state anxiety
score ‡ 34. Least square
means – standard error in
models adjusting for primi-
parity and infant age at study
visit. Group, time, and
group · time p values re-
ported for repeated measures
analysis with unstructured
covariance. At 2 weeks: n = 17
with higher symptoms, 29
with lower symptoms. At 8
weeks: n = 11 with higher
symptoms, 28 with lower
symptoms. *Simple effect p
value for group < 0.05 at this
time point. xGeometric means
presented because residuals in
untransformed analyses were
not normally distributed.
Table 2. Correlations Between Maternal Depression/
Anxiety and Oxytocin During Feeding at 8 Weeks
Postpartum, Among Participants Breastfeeding
or Pumping During the Study Visit
EPDS* STAI-State* STAI-Trait*
Oxytocin baseline - 0.22 20.44 - 0.22
0.18 0.01 0.17
Feeding minute 1 - 0.12 20.33 - 0.20
0.48 0.04 0.23
Feeding minute 4 - 0.27 20.38 - 0.23
0.10 0.02 0.17
Feeding minute 7 20.50 20.50 20.44
< 0.01 < 0.01 0.01





0.01 < 0.01 0.01
Oxytocin AUC 20.48 20.53 20.44
< 0.01 < 0.01 < 0.01
*Spearman R, p value. Spearman R coefficients with p < 0.05 are
shown in bold.
N = 39.
AUC, area under curve.
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These findings confirm and extend earlier work relating
maternal mood to breastfeeding experience and neuroen-
docrine markers during pregnancy and early postpartum.
We have previously reported that not liking breastfeeding in
the first 2 weeks was associated with depressive symptoms,
defined as EPDS > 12 at 2 months postpartum, in the Infant
Feeding Practices Study II.15 Poor maternal mental/emo-
tional health has also been associated with reduced odds of
exclusive breastfeeding at 6 months,26 and anxiety state prior
to hospital discharge predicted lower exclusive breastfeed-
ing at 3 months among first-time mothers.27 Furthermore, in
animal models, chronic maternal stress is associated with
reduced mothering behavior and pup growth.28 Contrary to
assertions that breastfeeding prevents postpartum depres-
sion,29 we found that exclusive breastfeeding at 2 weeks was
associated with increased mood symptoms at 8 weeks in our
sample.
Other authors have reported associations between lacto-
genic hormones and maternal mood. Skrundz et al. recently
reported an inverse association between oxytocin levels dur-
ing pregnancy and EPDS score ‡ 10 at 2 weeks postpartum.30
Nissen et al. measured the association between personality
and neuroendocrine markers in the early postpartum period
and found that, among women who gave birth by cesarean
section, anxiety was inversely correlated with basal oxytocin
and prolactin levels.31 Ours is the first study to our knowledge
to measure oxytocin response to the physiologic trigger of
breastfeeding among mothers with lower vs. higher mood
symptoms. Our findings associating lower oxytocin with
higher anxiety and depression suggest that oxytocin dysre-
gulation may contribute to perinatal mood disorders. Further
studies are needed to determine whether maternal mood is
similarly associated with differences in oxytocin response to
other mother–infant interactions.
Our finding of decreased total T4 among women with
higher EPDS scores is also consistent with earlier studies. In a
longitudinal study, lower mean total T4 and free T4 levels in
late pregnancy predicted more severe postpartum depression
ratings.32
In our sample, prolactin levels were lower among higher-
symptom mothers, although this difference was not statisti-
cally significant. Earlier work showed an inverse correlation
between alpha-adrenergic activity and prolactin area under
the curve during milk expression among mothers of preterm
infants,33 as well as inverse correlation between prolactin and
norepinephrine AUC during infant interaction in mothers of
term infants tested between 2 and 6 months postpartum.34
Other authors have found that both obesity35 and family
history of alcoholism36 are associated with blunted prolactin
response to suckling.
We also found a non-significant interaction between higher
maternal symptoms and CRF trajectory during breastfeeding.
This association merits exploration in future studies, given that
dysregulated cortisol and hypothalamic pituitary adrenal
(HPA) axis reactivity are among the most robust biological
findings in major depression39. In a longitudinal study (n = 17),
Magiakou et al.38 reported a diminished adrenocorticotropic
hormone (ACTH) response to ovine corticotropin-releasing
hormone (CRH) among women with postpartum depressive
symptoms, compared with euthymic mothers. Jolley et al.39
reported higher ACTH and lower cortisol following exercise
stress among depressed (n = 9) versus non-depressed (n = 13)
mothers at 12 weeks postpartum. These findings suggest that
HPA axis recovery following parturition is delayed in women
with mood symptoms.
We found interactions between higher maternal symptoms,
medication use, and neuroendocrine markers at 2 weeks (total
T4 and CRF) and 8 weeks (oxytocin). Because women with
FIG. 4. Median and interquartile range for maternal affect
during breastfeeding sessions at 2 weeks (A) and 8 weeks (B)
postpartum, among mothers with higher (dashed line) ver-
sus lower (solid line) mood symptoms, defined as EPDS ‡ 10
and/or Spielberger state anxiety score ‡ 34. At 2 weeks:
n = 17 with higher symptoms, 28 with lower symptoms. At 8
weeks: n = 11 with higher symptoms, 28 with lower. *Wil-
coxon p value for group < 0.05 at this time point.
358 STUEBE ET AL.
more severe disease are more likely to be treated, an obser-
vational study such as ours cannot separate the effect of
treatment from the severity of underlying disease. However,
antidepressants are known to modulate HPA axis function,
which may explain the association between medication use
and altered CRF trajectory at 2 weeks.40 This is the first study
to our knowledge to measure associations between medica-
tion use and oxytocin levels during breastfeeding. Animal
studies suggest that citalopram,41 but not fluoxetine,42 is as-
sociated with increases in oxytocin. We found that both higher
symptoms and antidepressant treatment were associated
with lower oxytocin levels during feeding, suggesting that
both underlying pathophysiology and antidepressant use are
associated with changes in oxytocin release. Our finding that
the women who had higher symptoms despite treatment had
the lowest oxytocin levels suggests that more severe illness is
associated with greater derangements of oxytocin physiology,
underscoring the importance of close follow-up, both for
management of mood symptoms and lactation support.
Given the small number of women in medication and higher-
symptom subgroups, further studies will be needed to vali-
date these findings.
This is the first study to our knowledge to measure asso-
ciations between maternal mood and neuroendocrine mark-
ers in established breastfeeding. Strengths of our study
include our prospective assessment of psychiatric history and
breastfeeding intention prior to birth and our use of stan-
dardized scales to measure maternal affect and infant feeding
patterns. We further limited our study population to women
intending to breastfeed at least three months, ensuring that
any weaning that occurred during the study period was un-
planned, and therefore more likely to reflect breastfeeding
difficulties than personal preference. However, our study also
has several limitations, and our findings must be interpreted
in the context of the study design. Our sample size was based
on the assumption that all mothers in the high-risk group
would have perinatal mood symptoms, but our study popu-
lation had only mild symptoms during follow-up. Using a
subclinical threshold, only 54% of high-risk women were
symptomatic at 8 weeks, reducing our power to detect dif-
ferences between symptomatic and asymptomatic women.
However, despite the mild symptoms among our partici-
pants, we found differences in oxytocin trajectories between
more and less symptomatic women. Multiple testing is also a
concern. We measured correlations with multiple markers at
three time points. Given the exploratory nature of study, we
did not adjust for multiple comparisons, and our findings
should therefore be viewed as preliminary. Our sample size
did not allow us to quantify the impact of maternal use of
galactogogues, pumping, and mixed feeding on our results.
Mothers who are experiencing breastfeeding problems may
adopt these strategies to compensate for an underlying neu-
roendocrine deficit, or use of these strategies may affect neu-
roendocrine profiles. Future crossover design studies
FIG. 5. Maternal neuroendocrine
profile during breastfeeding sessions
at 2 weeks (A) and 8 weeks (B) post-
partum, among mothers with higher
versus lower mood symptoms ( + Sx
vs. - Sx), defined as EPDS ‡ 10 and/
or Spielberger state anxiety score ‡ 34,
and with ( + ) or without (–) concurrent
antidepressant medication (Meds) use.
Least square means – standard error in
models adjusting for primiparity and
infant age at study visit. Group, time,
and group · time p values reported for
repeated measures analysis with un-
structured covariance. At 2 weeks:
n = 26 lower Sx / - Meds; n = 3 higher
Sx / - Meds; n = 10 higher Sx /
- Meds; n = 10 higher Sx / + Meds. At
8 weeks: n = 24 lower Sx / - Meds;
n = 4 higher Sx / - Meds; n = 5 higher
Sx / - Meds; n = 6 higher Sx / + Meds.
xGeometric means presented because
residuals in untransformed analyses
were not normally distributed.
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comparing within-subject profiles during pumping and
breastfeeding and with and without galactogogues may be
able to disentangle these issues.
Other authors have found that depressive symptoms in
the early postpartum period are associated with shorter
breastfeeding duration.11,12 We did not find an association
between maternal psychiatric history or higher mood
symptoms and breastfeeding discontinuation in our sample.
However, several factors limited our ability to evaluate this
association. Our sample size was small, we limited enroll-
ment to women intending to breastfeed, and follow-up
ended at 8 weeks postpartum. Longer follow-up may have
revealed differences in breastfeeding duration between more
symptomatic and less symptomatic groups. Furthermore,
fewer women than we anticipated experienced perinatal
depression symptoms. Moreover, many women in our co-
hort had previously successfully breastfed. It is possible that
with longer follow-up, we would have found differences in
breastfeeding duration or intensity. The socioeconomic
profile of our participants also differed from the general
population: more than half reported household in-
comes > $60,000 per year and post-graduate education. The
resources available to these women may have enabled them
to continue to breastfeed despite symptoms of depression or
anxiety. Further studies enrolling a more diverse population
of women are needed to address these issues.
In conclusion, in a prospective cohort study, we found that
higher symptoms of depression and anxiety were associated
with reduced oxytocin response to breastfeeding at 8 weeks
postpartum. These results support our hypothesis that ma-
ternal mood symptoms are associated with changes in neu-
roendocrine response to lactation. Such differences may both
predispose women to postpartum depression and interfere
with successful breastfeeding. Further research defining the
intersection of perinatal mood disorders and neuroendocrine
responses to breastfeeding may lead to novel strategies to
reduce maternal mood symptoms and enable women to
breastfeed successfully, thereby improving health outcomes
across two generations.
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